comprehensive -WSS

comprehensive

author：focus 2025-08-11 09:49:11 - browse：813

Balance innovation — Medicare laid out in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be. Adobe

WASHINGTON — Medicare laid out Wednesday in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be.

Democrats outlined some parts of the process in the Inflation Reduction Act that passed Congress last August, but the details of how drugs will be selected and what factors will be considered have been vague until now. Though the actual negotiated prices won’t take effect for years, Medicare officials must announce the first 10 drugs they’ll negotiate over by Sept. 1.

The guidance clarifies that the agency will choose the 50 pharmacy drugs that cost Medicare the most money, based on gross expenditures. If drugs have the same cost to the program, then the one that has been approved longer will be ranked higher.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： FDA seeks to regulate lab

WSS

How the Dana

Would Medicare drug price negotiations stall in a shutdown?

Recent heat wave in the Mediterranean caused by climate change: Study

Paxlovid should be available without a positive Covid test

Pandemic and All Hazards Preparedness Act needs lean update

See Ryan Reynolds, Hugh Jackman suited up in 1st look at 'Deadpool 3': Photo

hotspot

comprehensive

hotspot

Alkermes shareholders re

Health tech startups drop sharply from 2021 highs

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

How one patient went off dialysis — and others can too

The high cost of giving birth even with insurance

Address the ethical violations that led to 'Three Identical Strangers'

Moonlake's readout produced a cash windfall. Risks remain

Biden’s NIH nominee is languishing in Congress

Medical records are filled with copy

Data show record exodus of life scientists from academia

entertainment

Inequities make cancer less preventable for women: report

Researchers use wearables data and AI to predict preterm birth risk

Cigna to pay $172 million to settle Medicare Advantage fraud probe

The U.S. needs a new definition of substance use “recovery”

Pandemic and All Hazards Preparedness Act needs lean update

Medicaid, Medicare dual

focus

focus

focus

explore